logo

For the Inventor, By the Inventor

Durham, NC, United States of America

Jose Serafin Mendoza

This inventor holds 16 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Chaperone Therapeutics, Inc., Duke University, Eli Lilly and Company. Active years: 1996-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jose Serafin Mendoza. Retrieved from https://idiyas.com/inventor/jose-serafin-mendoza

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 

% Patents Active = 75.0

 

Average Co-Inventor Count = 2.8

ph-index = 6

Forward Citations = 269(Granted Patents)


Location History:

  • Durham, NC (US) (1996 - 2002)
  • New York, NY (US) (2018)
  • Chapel Hill, NC (US) (2008 - 2020)

Company Filing History:

goldMedal5 out of 5 
 
Chaperone Therapeutics, Inc.
 patents
silverMedal5 out of 2,085 
 
Duke University
 patents
bronzeMedal5 out of 4,517 
 
Eli Lilly and Company
 patents
4. 2 out of 3,300 
 
Genentech, Inc.
 patents
5. 1 out of 1 
 
Colossus Biopharma Consultants Company, Limited
 patent
6. 1 out of 102 
 
Icagen, Inc.
 patents
7. 2 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1996-2020

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents
1. 10744213 - Fluorescent compounds for imaging of blood vessels and blood flow, and an in vivo screen for pro- and anti-angiogenic agents (2020-08-18),
2. D819914 - Food scrap net (2018-06-05),
3. 9718784 - Substituted pyrazoles as heat shock transcription factor activators (2017-08-01),
4. 9717709 - Substituted pyrazoles as heat shock transcription factor activators (2017-08-01),
5. 9447058 - Substituted 1,3-thiazoles as heat shock transcription factor 1 activators (2016-09-20),
6. 9315449 - Substituted pyrazoles as heat shock transcription factor activators (2016-04-19),
7. 9156775 - Substituted 1,3-thiazoles as heat shock transcription factor 1 activators (2015-10-13),
8. 7795290 - 2-amido-thiazole-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof (2010-09-14),
9. 7410988 - 2-Amido-thiazole-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof (2008-08-12),
10. 6429317 - Indane derivatives for antipsychotic compositions (2002-08-06),
11. 6395735 - Pharmaceutical compounds (2002-05-28),
12. 6395730 - Potassium channel inhibitors (2002-05-28),
13. 6174908 - Potassium channel inhibitors (2001-01-16),
14. 6083986 - Potassium channel inhibitors (2000-07-04),
15. D414271 - Reaction vessel for combining chemicals (1999-09-21),

Title: Innovations and Contributions of Jose Serafin Mendoza

Introduction

Jose Serafin Mendoza is a notable inventor based in Durham, NC (US). He holds a total of 16 patents, showcasing his significant contributions to the field of innovation. His work primarily focuses on advancements in pharmaceutical compositions and methods.

Latest Patents

Among his latest patents is the "Food Scrap Net," which addresses the need for efficient waste management. Additionally, he has developed indane derivatives for antipsychotic compositions. This invention provides novel indane-like compounds that can be useful for treating psychosis and other conditions associated with the modulation of a muscarinic receptor. The invention also includes formulations and methods for utilizing these novel compounds effectively.

Career Highlights

Throughout his career, Jose has worked with prominent companies, including Eli Lilly and Company. His experience in the pharmaceutical industry has greatly influenced his innovative endeavors.

Collaborations

Jose has collaborated with several professionals in his field, including Sean Patrick Hollinshead and Philip Floyd Hughes. Their combined expertise has contributed to the success of his projects.

Conclusion

Jose Serafin Mendoza's work exemplifies the spirit of innovation and dedication to improving healthcare through his inventions. His contributions continue to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…